This article deconstructs the IIH guidelines, contrasting medical management (acetazolamide, topiramate) with the practical ...
Please provide your email address to receive an email when new articles are posted on . Later idiopathic intracranial hypertension diagnoses occurred less often in women with slightly lower ...
Patients with ‘blinding’ headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found. The study, published ...
Int Ophthalmol Clin. 2014;54(1):27-41. Much of the data supporting weight loss as treatment for IIH comes from retrospective studies or class III evidence. There has been a long-standing need for ...
Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes, may be a potential treatment for idiopathic intracranial hypertension (IIH). In a small phase 2 trial, ...
AUSTIN, Texas — Venous manometry and neuroimaging may provide additional value when diagnosing patients who do not meet criteria for idiopathic intracranial hypertension, according to a poster ...
Doctors think they've figured out a way to predict who might lose vision due to a high brain pressure disorder. Idiopathic intracranial hypertension occurs when there's unexplained pressure buildup in ...
Weight loss surgery is more effective than dieting to reduce brain pressure that can cause blindness in patients with a neurological condition, finds a study led by the University of Birmingham and ...
TALLAHASSEE, Fla – Imagine finding out you have a life altering illness– when you only believed you needed glasses. That’s exactly what happened to one woman who suffers from Idiopathic Intracranial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results